Comparing regional and global diffusion MRI markers as biomarkers of VCID
Sheelakumari Raghavan(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic in Arizona), Jonathan Graff‐Radford(Mayo Clinic), Robert I. Reid(Mayo Clinic), Scott A. Przybelski(Mayo Clinic in Florida), Timothy G. Lesnick(Mayo Clinic in Florida), Michael G. Kamykowski(Mayo Clinic), David S. Knopman(Mayo Clinic in Arizona), Val J. Lowe(Mayo Clinic), Ronald C. Petersen(University of California, Los Angeles), Clifford R. Jack(Mayo Clinic)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k